Big Moves & Market Buzz | Stocks in Focus Today.

Here’s a roundup of key developments that could drive stock action on July 16: Dixon Technologies: is making major expansion moves. It will acquire 51% stake in Q Tech India, aiming to strengthen its presence in mobile camera and fingerprint modules for phones, IoT, and autos. Additionally, Dixon plans a new JV with Chongqing Yuhai, with a 74:21 ownership, to manufacture precision parts for mobiles, laptops, and cars in India. Kotak Mahindra Bank: announced that Phani Shankar, President & Chief Credit Officer, has resigned. His exit will be effective from July 21. Zydus Lifesciences: received final USFDA approval for its Celecoxib capsules (50–400 mg), used to relieve pain and inflammation in arthritis and other conditions. Biocon Biologics: a subsidiary of Biocon, got a big win with USFDA approval for KIRSTY (Insulin Aspart)—the first interchangeable biosimilar to NovoLog. It’s a rapid-acting insulin for diabetes patients, set to boost Biocon’s global presence. Bajaj Finserv: gets regulatory nod from IRDAI to take over 26% stake held by Allianz SE in its insurance arms—Bajaj Allianz Life & General Insurance. This move increases promoter holding and simplifies ownership structure. Jindal Steel & Power: CFO Mayank Gupta has resigned, effective July 15, citing personal reasons. MAS Financial Services: saw a bulk deal where Nippon India MF acquired 20 lakh shares at ₹305 each. As of March 2025, Nippon held a 5.29% stake, now set to rise. IPO Watch: Asston Pharmaceuticals, an SME, is listing today—investors may watch for debut performance. In summary: Major expansions by Dixon, approvals for Zydus and Biocon, reshuffling in top banks and firms, and strategic stake transfers at Bajaj Finserv make these stocks worth tracking closely today.